Prepared as a catalog companion to the model testing report.
Ingredient list
Declared composition for a LIRAVEXIN catalog item — not a tested result
Declared ingredients
| Ingredient | Amount as declared | Public identity |
|---|---|---|
| AOD-9604 | 10 mg | A modified fragment related to the C-terminal region of human growth hormone (hGH 176–191), with an N-terminal tyrosine. Public sequence / structure: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (disulfide between the two cysteine residues) |
| Other constituents | — | Not declared on the catalog label. No excipient (for example a bulking agent, counter-ion or residual moisture) is assumed here. |
Amino-acid sequences, where shown, are well-known public identities of the named substance. If a sequence could not be stated with confidence, it has been omitted rather than guessed.
Permalink
The QR code on the model report opens this page.
Published address:
https://gs-laboratory.com/ingredients/10ad.html
This is the published address of this ingredient list.
Notes
This ingredient list is a declared composition for the catalog item. It is not a Certificate of Analysis and not a statement of purity, identity or content as measured in a laboratory.
The catalog item is a research product, not a medicinal product. This page is not medical advice, not a dosing guide, and not a marketing claim. GS Laboratory does not manufacture or sell peptides or medicines.